Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients?

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
I García-EscobarCancer and Thrombosis Working Group of the Spanish Society of Medical Oncology (SEOM)

Abstract

The association between venous thromboembolism (VTE) and cancer has been recognized for more than 100 years. Numerous studies have been performed to investigate strategies to decrease VTE incidence and to establish whether treating VTE impacts cancer progression and overall survival. Accordingly, it is important to understand the role of the hemostatic system in tumorigenesis and progression, as there is abundant evidence associating it with cell survival and proliferation, tumor angiogenesis, invasion, and dissemination, and metastasis formation. In attempts to further the scientific evidence, several studies examine survival benefits in cancer patients treated with anticoagulant therapy, specifically treatment with vitamin K antagonists, unfractionated heparin, and low-molecular-weight heparin. Several studies and meta-analyses have been conducted with a special focus on brain tumors. However, no definitive conclusions have been obtained, and more well-designed clinical trials are needed.

References

Jan 1, 1991·Clinical & Experimental Metastasis·L Daly
Jan 1, 1990·Immunopharmacology and Immunotoxicology·D M SylvesterG G Meadows
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A P ChahinianR L Comis
Jan 1, 1986·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·A N PapaioannouJ K Papageorgiou
Jul 1, 1993·International Journal of Colorectal Disease·R D KingstonM K Palmer
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·K AkaogiK Miyazaki
Jan 1, 1997·British Journal of Cancer·G C Jayson, J T Gallagher
Jul 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D NittiF Roelofsen
Nov 18, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L H MaurerM R Green
Jan 16, 1999·Journal of the National Cancer Institute·M HejnaC C Zielinski
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·L BorsigA Varki
Aug 23, 2001·Thrombosis Research·F R Rickles, A Falanga
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lubor BorsigAjit Varki
Mar 28, 2003·Neoplasia : an International Journal for Oncology Research·Eva L LundPaul E G Kristjansen
Aug 16, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Alok A KhoranaCharles W Francis
Aug 28, 2003·Journal of Thrombosis and Haemostasis : JTH·A AmirkhosraviJ L Francis
Sep 13, 2003·Chest·Frederick R RicklesPatricia M Fernandez
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ajay K KakkarRobin C N Williamson
Nov 16, 2004·Thrombosis and Haemostasis·Hatem A MousaCheng-Hock Toh
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clara P W KlerkHarry R Büller
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Agnes Y Y LeeMark N Levine
Jun 1, 2005·The Lancet Oncology·Paolo PrandoniAndrea Piccioli
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer L StevensonAjit Varki
Jun 15, 2006·Mayo Clinic Proceedings·Kostandinos SiderasCharles L Loprinzi
Apr 6, 2007·Journal of Thrombosis and Haemostasis : JTH·A Lazo-LangnerM A Rodger
Oct 18, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Catherine WeberGilbert B Zulian
Jan 30, 2009·Pathophysiology of Haemostasis and Thrombosis·Keren S Borensztajn, C Arnold Spek
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carla Boccaccio, Paolo M Comoglio
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicole M KudererCharles W Francis

❮ Previous
Next ❯

Citations

Oct 24, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jan Moritz PonertMartin Schlesinger
Jan 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Noemi VeraldiAriane de Agostini
Nov 11, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cinzia Lanzi, Giuliana Cassinelli
Jan 26, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A J Muñoz MartínM Salgado Fernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nicole M KudererCharles W Francis
Seminars in Thrombosis and Hemostasis
Anna Falanga, Marina Marchetti
© 2022 Meta ULC. All rights reserved